Navigation Links
BioDiscovery Joins Illumina Connect Bioinformatics Program

- Integrates Nexus CGH with Illumina's BeadStudio Software -

EL SEGUNDO, Calif., Nov. 13 /PRNewswire/ -- BioDiscovery announced today that it joined Illumina Connect, a bioinformatics program offered by Illumina, Inc., for downstream analysis of microarray data. After collaborating with Illumina, BioDiscovery has successfully created an interface that allows customers using both Illumina's BeadStudio software to seamlessly process their data in BioDiscovery's Nexus CGH advanced copy number analysis software.

Nexus CGH is BioDiscovery's platform-independent solution for the analysis and visualization of multiple samples for identification of regions of chromosomal gain and loss in a population, and performing statistical association studies. Nexus CGH can easily handle large projects including those with thousands of Illumina high-density arrays.

Omoshile Clement, Ph.D., Illumina's Senior Product Manager of Platforms said, "Interest in Illumina Connect has continued to grow because bioinformatics software and service providers recognize the value that Illumina technology brings to their customers. Now that BioDiscovery is a partner, we are excited to work with them to make it easier for customers to access the power of Illumina's genotyping applications for their studies."

"BioDiscovery's drive for platform independence has been realized with Nexus CGH, said Dr. Soheil Shams, President of BioDiscovery. "We are delighted to work with Illumina to create an interface between our products, and to create greater value for scientists and the medical community looking to advance their downstream analysis functionality," said Dr. Shams.

"The user-friendly Nexus interface enables researchers to answer important biological questions without the need for advanced statistical or programming knowledge. With the integration of Illumina's BeadStudio and Nexus CGH, our customers can go from raw data to biological insight in a matter of minutes," said Dr. Shams.

About BioDiscovery, Inc.

BioDiscovery is a leader in the development of microarray advanced bioinformatics software and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. Contact us: 310-414-8100 or


Soheil Shams


BioDiscovery, Inc.

310.414.8100 x221

SOURCE BioDiscovery, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization
2. Richard Greco Joins Mediware Board
3. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
4. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
5. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
6. Nick Childs Joins Grey New York as Director of Content Development
7. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
8. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
9. NASN Joins Partnership to Fight Chronic Disease
10. AstraZeneca Joins Local Walking Movement
11. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
Post Your Comments:
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... (HLA), the nation's first interactive health literacy software tool, and the Cancer Patient ... aspects of cancer patient education, today announce a new strategic alliance. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... of California Berkeley, and other leading institutions in announcing the launch of the ... to change the way animals are raised for food. , Founding members of ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
Breaking Medicine Technology: